Myeloid dendritic cells in HIV-1 infection
Document Type
Article (peer-reviewed)
Publication Date
2011
Abstract
Purpose of review: Myeloid dendritic cells (mDCs) are pivotal players in HIV-1 infection. They promote transmission and spread and at the same time are critical for recognizing HIV-1 and initiating immune responses to fight infection. Notably, their immunostimulatory capabilities can be harnessed to design better HIV-1 vaccines. In this review, advances in these areas of mDC-HIV-1 interactions are summarized. Recent findings: New insights into HIV-1-induced dysfunction of mDCs and dysfunctional mDC effects on other cell types, as well as novel mechanisms of viral sensing by mDCs and their evasion by HIV-1, have been uncovered. These results emphasize the importance of mDCs in protection against HIV-1 infection. Targeting mDCs with vaccines and tailored adjuvants may improve the quality and anatomical location of elicited immune responses. Summary: Understanding the multiplicity of HIV-1-dendritic cell interactions together with the numerous advances in targeted therapy and vaccination will help in the rational design of approaches to treat and block infection.
Recommended Citation
Derby, Nina, Elena Martinelli, and Melissa Robbiani. 2011. "Myeloid dendritic cells in HIV-1 infection," Current Opinion in HIV and AIDS 6(5): 379–384.
DOI
10.1097/COH.0b013e3283499d63
Language
English